Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

3.500 +0.050 (+1.45%)
Streaming Delayed Price Updated: 10:02 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 662,787
Open 3.450
Bid (Size) 3.490 (38)
Ask (Size) 3.500 (18)
Prev. Close 3.450
Today's Range 3.420 - 3.530
52wk Range 1.680 - 4.050
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected... 
Via Benzinga
Topics Stocks
Exposures US Equities
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO). 
Via Benzinga

Performance

YTD
+63.55%
+63.55%
1 Month
+10.24%
+10.24%
3 Month
+77.66%
+77.66%
6 Month
+84.21%
+84.21%
1 Year
+70.73%
+70.73%

More News

Read More
The Latest Analyst Ratings For Geron
Via Benzinga
Geron to Participate at Upcoming Investor Conferences in April
From Geron Corporation
Via Business Wire
Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading
Via Investor Brand Network
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
Via MarketBeat
Exposures Product Safety
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
What's Going On With Cancer Focused-Geron Stock On Friday?
Via Benzinga
Exposures Product Safety
Why Is Geron (GERN) Stock Up 94% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Geron Stock Is Soaring After Hours: What's Going On?
Via Benzinga
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
From Geron Corporation
Via Business Wire
Why Geron Stock Is Falling Today
Via Benzinga
Exposures Product Safety
FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment
Via Benzinga
Exposures Product Safety
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Geron (GERN) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Via Talk Markets
Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.